Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant - Priority Announcement: Aging

Université de Montréal

$100,000.00

Investigation of the heterogeneity of mitochondrial dysfunction in idiopathic Parkinson's disease using induced neurons derived from patients

FY 2022-23

Summary
Neurodegenerative disorders, which include Parkinson's disease (PD), are common and likely to increase as we all live longer. These conditions are incurable and place a huge burden on our Canadian healthcare systems, as well as on patients, care givers and families. There is therefore a pressing need to better understand these diseases with the expectation that it will lead to the development of therapies that stop their progression. The motor symptoms in PD are originating from the loss of dopamine cells in the brain. However, how exactly this occurs is not fully understood, given the lack of experimental systems that faithfully recapitulate the human condition. This project takes advantage of a new technology to generate dopamine cells from skin cells of PD patients. In contrast to other technologies available, this new method produces cells that are the same age as the donor, thus keeping the vulnerability associated to older age, which is crucial since the most important risk factor for PD is aging. We will thus study what triggers cell death, and whether those triggers are the same for every case of PD. This project is unique in providing, for the first time, brain cells in a dish that will allow the dissection of events leading to cell death in a context that can be specific to each patient. As such, in the future this new approach could be used not only for identifying drugs that stops the disease progression, but also for tailoring therapies to best suit each patient in a personalized medicine manner.
Program
Project Grant - Priority Announcement: Aging
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
472305
Name
Drouin-Ouellet Janelle
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Molecular & Cellular Neurosciences - B
Projecttitle
Investigation of the heterogeneity of mitochondrial dysfunction in idiopathic Parkinson's disease using induced neurons derived from patients
Programtype2
Operating Grants
Orgnameinp2
Université de Montréal
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - Priority Announcement: Aging
Keyworddelim
Dopaminergic Neurons; Induced Neurons; Induced Pluripotent Stem Cells; Mitochondrial Dysfunction; Mitophagy; Parkinson'S Disease
Abstract
Neurodegenerative disorders, which include Parkinson's disease (PD), are common and likely to increase as we all live longer. These conditions are incurable and place a huge burden on our Canadian healthcare systems, as well as on patients, care givers and families. There is therefore a pressing need to better understand these diseases with the expectation that it will lead to the development of therapies that stop their progression. The motor symptoms in PD are originating from the loss of dopamine cells in the brain. However, how exactly this occurs is not fully understood, given the lack of experimental systems that faithfully recapitulate the human condition. This project takes advantage of a new technology to generate dopamine cells from skin cells of PD patients. In contrast to other technologies available, this new method produces cells that are the same age as the donor, thus keeping the vulnerability associated to older age, which is crucial since the most important risk factor for PD is aging. We will thus study what triggers cell death, and whether those triggers are the same for every case of PD. This project is unique in providing, for the first time, brain cells in a dish that will allow the dissection of events leading to cell death in a context that can be specific to each patient. As such, in the future this new approach could be used not only for identifying drugs that stops the disease progression, but also for tailoring therapies to best suit each patient in a personalized medicine manner.
Competitiondate
202209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Drouin-Ouellet, Janelle
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
Université de Montréal - $100,000 Grant (2022-23) | Canada Spends